bpc-157 human clinical trials evidence review safety regulatory status If worked as well as the internet says it does… …we'd probably have high quality by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of BPC-157: What you need to
Description
The subsequent Phase IIb OPTIONS trial enrolled 536 subjects over 24 weeks
BPC-157 is most associated in animal studies with new blood vessel formation and tissue protection at the injury site
Be gentle to avoid shaking or disturbing the contents inside
publicly stated during a Joe Rogan podcast appearance and reiterated in follow-up HHS communications that the FDA would return 14 of 19 previously Category 2 peptides to Category 1 compounding status
Promising in animals, limited in humans
